department of bacteriology, niigata universiy …...department of bacteriology, niigata universiy...

1
Department of Bacteriology, Niigata Universiy Graduate School of Medical and Dental Sciences Yuriko Ozeki, Sohkichi Matsumoto Contact us: Niigata University, Institute for Social Innovation and Cooperation TEL:025-262-7554 FAX:025-262-7513 E-mail:[email protected] Summary Subject Details/Topic We established antigenic protein expression system in rapid growing acid fast bacteria, Mycobacterium smegmatis and purification technique of expressed protein. One of antigenic proteins, MDP1 (Mycobacterial DNA-binding Protein 1) obtained by this system (mMDP1), activated human PBMC from BCG-vaccinated donors stronger than MDP1 obtained from conventional E. coli expressing system (eMDP1). These techniques is useful for production of immunogenic protein for vaccine development and diagnostic use against TB. Advantages 1. mMDP1 possesses post translational modification which eMDP1 does not. Our technique enables to obtain antigens with molecular function unique to acid fast bacteria. 2. mMDP1 activates protective immunity stronger than eMDP1. 3. No LPS removal required. Applications The antigenic proteins obtained by our expression system and purification technique are expected to be useful for vaccine development, analysis of molecular function, and diagnosis against TB. Plans Component vaccine development against tuberculosis. Diagnostic antigen preparation of mycobacterial diseases. Verify the effectiveness of mMDP1 in primates close to the human. We hope to collaborate with… Mycobacterium tuberculosis causes a leading death among single infectious agents worldwide. Development of new vaccine against tuberculosis and more accurate diagnostic methods are argent need. We have established antigenic protein expression and purification system in mycobacteria. The purified protein by this system is more immunogenic than that obtained by conventional E. coli system, suggesting its usefulness for production of vaccine and immune response-based diagnostic components. Establishment of antigenic protein expression system in acid fast mycobacteria and purification technique of the expressed protein. 抗酸菌での抗原性タンパク質の発現と精製技術 KeywordsTuberculosis Vaccine MDP1 Protein expression system in acid fast bacteria Protein purification The manufacturer of mycobacterial protein by GMP. pSO246::ACE-mdp1 (Rv2986c)-His6 8.0 kb n e o ColE pA L50 0 0 o r i Acet amidase reg ul ator A c e t a m i d as e R e g u l a t o r r e g i o n Electroporlation M. smegmatis mc 2 _155Δmdp1 Construction of protein expression system in acid fast mycobacteria. Protein purification technique The advantage of mMDP1 in IFN-gamma production from PBMC. G9.1 as adjuvant augments it’s production. 0 5000 10000 15000 20000 25000 30000 none eMD P1 mMD P1 none eMD P1 mMD P1 IFN-gamma (pg/ml) 0.5 µM Day 3 0.5 µM Day 5 QFT陽性歴を有するヒトPBMC 健常者PBMC 0 50 100 150 200 none eMDP1 eM DP1+G9.1 m MDP1 mMDP1+G9.1 IFN-gamma (pg/ml) 0.5 μM Day 5 ** ** ** ** Donor with QFT positive history Donor: Healthy control Our techniques contribute to G9.1 mMDP1 Vaccine development Diagnosis Analysis of molecular function against TB and mycobacterial diseases

Upload: others

Post on 25-Jun-2020

25 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Department of Bacteriology, Niigata Universiy …...Department of Bacteriology, Niigata Universiy Graduate School of Medical and Dental Sciences Yuriko Ozeki, Sohkichi Matsumoto Contact

Department of Bacteriology, Niigata Universiy Graduate School of Medical and Dental Sciences

Yuriko Ozeki, Sohkichi Matsumoto

Contact us: Niigata University, Institute for Social Innovation and CooperationTEL:025-262-7554 FAX:025-262-7513 E-mail:[email protected]

■Summary

■Subject Details/Topic

We established antigenic protein expression system in rapid growing

acid fast bacteria, Mycobacterium smegmatis and purification technique

of expressed protein. One of antigenic proteins, MDP1 (Mycobacterial

DNA-binding Protein 1) obtained by this system (mMDP1), activated

human PBMC from BCG-vaccinated donors stronger than MDP1

obtained from conventional E. coli expressing system (eMDP1). These

techniques is useful for production of immunogenic protein for vaccine

development and diagnostic use against TB.

○Advantages

1. mMDP1 possesses post translational modification which eMDP1

does not. Our technique enables to obtain antigens with molecular

function unique to acid fast bacteria.

2. mMDP1 activates protective immunity stronger than eMDP1.3. No LPS removal required.

○Applications

The antigenic proteins obtained by our expression system and

purification technique are expected to be useful for vaccine

development, analysis of molecular function, and diagnosis against TB.

○Plans

Component vaccine development against tuberculosis.

Diagnostic antigen preparation of mycobacterial diseases.

Verify the effectiveness of mMDP1 in primates close to the human.

■We hope to collaborate with…

Mycobacterium tuberculosis causes a leading death among singleinfectious agents worldwide. Development of new vaccine againsttuberculosis and more accurate diagnostic methods are argent need.We have established antigenic protein expression and purificationsystem in mycobacteria. The purified protein by this system is moreimmunogenic than that obtained by conventional E. coli system,suggesting its usefulness for production of vaccine and immuneresponse-based diagnostic components.

Establishment of antigenic protein expression system in acid fast mycobacteria

and purification technique of the expressed protein.

抗酸菌での抗原性タンパク質の発現と精製技術

【Keywords】Tuberculosis Vaccine MDP1

Protein expressionsystem in acid fast bacteria

Protein purification

The manufacturer of mycobacterial protein by GMP.

pSO246::ACE-mdp1(Rv2986c)-His6

8.0kb

neo

ColE

pAL5000ori

Acetamidase

regulator

Acetam

idase

Regu

latorregio

n

Electroporlation

M. smegmatis mc2_155Δmdp1

Construction of protein expression system

in acid fast mycobacteria.

Protein purification technique

The advantage of mMDP1 in IFN-gamma production from PBMC.

G9.1 as adjuvant augments it’s production.

0

5000

10000

15000

20000

25000

30000

none

eMD

P1

mMD

P1

none

eMD

P1

mMD

P1

IFN

-ga

mm

a (

pg/m

l)

0.5 µM

Day 3

0.5 µM

Day 5

QFT陽性歴を有するヒトPBMC 健常者PBMC

0

50

100

150

200

none

eMDP1

eMDP1+G9.1

mMDP1

mMDP1+G9.1

IFN-gamma(pg/m

l)

0.5μMDay5

****

**

**

Donor with QFT positive history Donor: Healthy control

Our techniques contribute toOur techniques contribute to

G9.1

mMDP1

Vaccine development

Diagnosis Analysis of

molecular function

against TB and mycobacterial diseasesagainst TB and mycobacterial diseases